2025
Full relocation completed. Four times the former site area, with automated warehousing and cleanrooms — Hsiner enters its next chapter.
2024
R&D and Marketing relocated to the new Houli facility, beginning the transition.
2022
Initiated EU MDR compliance preparation for European market entry.
2019
Achieved MDSAP certification, meeting regulatory requirements across five countries.
2006
Relocated to Shengang headquarters; achieved GMP and ISO 13485 certification
2002
Obtained U.S. FDA listing, entering the international medical market.
1993
Hsiner founded in Taichung, Taiwan, specializing in respiratory care consumables.